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Abstract
An immunomodulatory protein (IPAF) was purified and cloned from Anoectochilus formosanus, an Orchidaceae herbal plant
in Asia. The major targeting immune cells of IPAF and its modulating effects toward B lymphocytes were investigated. Rapid
amplification of cDNA ends (RACE) was conducted to clone the IPAF gene, and the obtained sequence was BLAST
compared on the NCBI database. MACS-purified mouse T and B lymphocytes were stimulated with IPAF and the cell
proliferation, activation, and Igs production were examined. IPAF comprised a 25 amino acids signal peptide and a 138
amino acids protein which was homologous to the lectins from Orchidaceae plant. IPAF selectively induced the cell
proliferation in mouse splenic B lymphocytes but not T lymphocytes. The IPAF-induced B cells exhibited increased CD69 and
MHC class II expression, and a dose- and time-dependent enhancement in IgM production. These results suggested
potential benefits of IPAF to strengthen the humoral immunity.
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Introduction
Anoectochilus formosanus is an herbal plant widely used as dietary
supplement and folk remedy in Asia. It provided numerous health
benefits such as hepatoprotection [1–4], anti-fatigue [5], anti-
oxidative [6,7], anti-hyperglycemia [8], anti-hyperliposis [4], anti-
osteoporosis [9,10], anti-tumor [11,12], and immune modulation.
The aqueous extraction of A. formosanus was reported to stimulate
lymphoid tissue and peritoneal macrophages [11]. Another study
using an ovalbumin-inhaled murine model indicated the admin-
istration of A. formosanus extract was capable of modulating
cytokine secretion and regulatory T cell population in broncho-
alveolar lavage fluid [13]. However, the bioactive components of
A. formosanus are still unclear.
B lymphocytes are the central mediator of humoral immunity and play
a pivotal role in host defense. Upon encountering with antigen through B
cell receptors (BCR), B cells could proliferate and differentiate into effector
plasma cells through a highly regulated process and neutralized pathogens
by secreting antigen-specific antibodies [14]. B cells are antigen presenting
cells capable of breaking down antigens into small peptide fragments which
are presented on the major histocompatibility complex (MHC) located on
the surface of B cells [15,16], thus allowing recruitment of cognate CD4
+T
helper cells to facilitate the complete activation of B cells. Antigens
recognized by B cells can be divided into two categories, T cell-dependent
(TD) antigen and T cell-independent (TI) antigen. The latter can be further
categorized into TI type-1 (TI-1) and TI type-2 (TI-2) antigens [17]. B cells
activated by TD antigens such as tetanus, diphtheria, and pertussis toxin
require cognate help from T cells for complete activation. TI-1 antigen
such as LPS or bacterial DNA can activate B cell through antigen-BCR
interactions and additional signals provided by other receptors such as Toll-
like receptors (TLRs). TI-2 antigen such as multivalent polysaccharide or
antigen with repetitive structure could activate antigen-specific B cells
through extensive cross-linking of BCRs [18].
In the current study, we purified a novel protein from fresh A.
formosanus. To characterize this protein, its N-terminal amino acid
sequence was determined and its cDNA sequence was cloned using
RACE method. Moreover, we observed that this protein was capable
to induce mouse peritoneal macrophages and splenic lymphocytes
a n dd e s i g n a t e di ta sa nimmunomodulatory protein from A.
formosanus (IPAF). The IPAF-stimulated cell activation and
maturation of mouse B lymphocytes were investigated. The necessity
of T lymphocytes and the involvement of TLR2 and TLR4 within
this induction were also evaluated. To our knowledge, IPAF is the
first Orchidaceae protein reported to activate B lymphocytes as a TI
antigen.
Results
Purification and biochemical characteristics of IPAF
To isolate the novel protein from A. formosanus, the crude protein
solution was obtained by means of homogenization, sonication and,
precipitation. The total protein yield was 1.67 g crude protein per kg
plant weight. Subsequently, the crude protein extract was fraction-
ated using a DEAE-52 cellulosecolumneluted with linear gradient of
0.0–1.0 M NaCl. The elution profile acquired by BCA protein
concentration analysis exhibited one major peak (Fig. 1A), which was
collected to determine the stimulatory activity toward mouse
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view of significant increase in TNF-a production in RAW264.7
(Supporting Information S1). The SDS-PAGE analysis of these
fractions revealed two protein bands (Supporting Information S2).
The fractions were pooled for protein yield calculation (0.25 g per kg
plant weight) and further purification with the fast protein liquid
chromatography (FPLC) system. The sample was loaded on
HiTrapQ anion exchange column and eluted with a linear gradient
of 0.0–1.0 M NaCl. The elution profile was obtained by measuring
the absorbance at 280 nm and revealed a single peak (Fig. 1B). The
fractions corresponding to this peak were pooled for protein yield
calculation (86.7 mg per kg plant weight) and SDS-PAGE analysis. A
single 14 kDa protein band could be observed after CBR staining
(Fig. 1C). The SDS-PAGE was also stained with PAS reagent for
carbohydrate content determination, where the result suggested that
this protein is not a glycoprotein (Fig. 1C). This 14 kDa protein was
capable of up-regulating the TNF-a and IFN-c secretion by
RAW264.7 cells and murine splenocytes, respectively (Supporting
Information S3, S4), and was then believed to be an immunomod-
ulatory protein from Anoectochilus formosanus (IPAF). Viewing on
the fact that the IPAF sample examined in SDS-PAGE was reduced,
it was possible that the observed 14 kDa band might be a subunit if
the protein constituted two or more subunits. To investigate whether
IPAF was a monomeric protein, we compared the MW of reduced
and non-reduced IPAF by gel-filtration capillary electrophoresis. The
non-reduced IPAF sample was prepared under conditions where the
intermolecular bondings such as disulfide bonds and hydrogen bonds
were preserved. As shown in Fig. 1D, the migration time of reduced
and non-reduced IPAF were very close, and the MW, as calculated
with protein size standard curve, were 14.2 and 14.3 kDa for reduced
and non-reduced IPAF, respectively. Since the intermolecular
bondings were saved in the non-reduced sample, the MW would
have been larger if it constituted more subunits. This finding
confirmed that IPAF was a monomeric protein, and the 14 kDa
protein band observed on SDS-PAGE was indeed IPAF. To facilitate
future research, we used immunized mouse splenocytes and fused
them with mouse leukemia cell line X63 to generate monoclonal
hybridoma secreting antibodies specifically against IPAF. The
specificity of the monoclonal antibody was validated via Western
blot analysis (Fig. 1C).
Molecular cloning of IPAF
To obtain the amino acid sequence of IPAF, purified IPAF
separated by SDS-PAGE was transferred onto a PVDF membrane
and subjected to Edman degradation for N-terminal sequence
determination. The resulted sequence, ASSLGTGGTLRNN, did
not belong to any known protein under the BLAST search of
NCBI database. Additionally, the lack of methionine at the N-
terminus suggested that the mRNA-translated IPAF could contain
a hydrolysable signaling sequence in its amino terminal side.
Taking advantage of the N-terminal amino acid sequence of IPAF,
we adopted the RACE approach to clone the IPAF gene. The 39-
RACE was performed using a gene-specific primer a36, and a
700 bp DNA fragment (designated as PRa36) was attained. The
N-terminal amino acid sequence of an ORF of this DNA fragment
was fully identical to the sequence of IPAF (Supporting
information S5), suggesting that PRa36 was a candidate for the
39 portion of the IPAF gene. To achieve the complete cDNA of
IPAF, a primer (b18) with a sequence from nucleotide position 358
to 378 of the PRa36 fragment was further designed and utilized to
conduct the 59-RACE PCR, by which a 600 bp DNA fragment
(PRb18) was generated. The 26
th to 38
th amino acid residues of
translated PRb18 sequence were identical to the N-terminal amino
acid sequence of IPAF (Supporting Information S5). By merging
the corresponding two ORFs of PRa36 and PRb18, the complete
cDNA sequence of IPAF was obtained (Fig. 2A). It was 654 bp in
length, including 474-bp ORF encoding 158 amino acids and 151-
bp 39-UTR. The first 25 amino acid residues were putative signal
peptide (possibility of ,0.90) as predicted by the SignalP program
(Supporting information S6). The peptide may be cleaved during
post-translational modification or secretion of IPAF (Fig. 2B). The
nucleotide sequence of IPAF has been deposited in the GenBankH
database under accession no. ADK74829.
Homology analysis of IPAF to Orchidaceae lectins
Comparisons between the amino acid sequence of IPAF and
other sequences using the protein BLAST program via NCBI
revealed a close relation between IPAF and the plant lectin of
Epipactis helleborine (AAA19577.1), gastrodianin-4B of Gastrodia elata
(AAX10109.1), and lectin of Listera ovata (AAA20899.1). Multiple
alignment of IPAF amino acid sequence with these proteins
(Fig. 2C) displayed considerable sequence identities and similarities
as compiled in Table 1. Notably, E. helleborine, G. elata and L. ovata
all belong to the Orchidaceae family. The hemagglutinating
activity of IPAF was also examined and revealed that IPAF, at
1.0 mg/mL or below, agglutinated neither mouse nor human
erythrocytes (Supporting information S7). This result coincide with
the discovery of Van Damme et al. [19] where one class of lectins
devoid of erythrocyte agglutinating activity was isolated from L.
ovata and E. helleborine. Hence, these findings suggested the close
relation between IPAF and Orchidaceae lectins.
B lymphocytes as the major targets activated by IPAF
Preliminary studies of IPAF have revealed the capability of IPAF
in activating mouse splenocytes (Supporting Information S4). We
therefore examined the major target cells regulated by IPAF. After
72 hours of induction, a remarkable and dose-dependent increase in
cell proliferation by mouse splenocytes was observed, indicating that
IPAF (1–16 mg/mL) was capable of enhancing mouse splenocytes
proliferation (Fig. 3A). It has been known that splenocytes were
mainly consisted of T and B lymphocytes, which played crucial roles
in immune responses. We further determine the stimulatory effect of
IPAF on mouse T and B lymphocytes. The primary T and B
lymphocytes (CD90
+ and CD19
+ cells), which were positively
selected from splenocytes of BALB/c with cell purity above 95%,
were co-cultured with IPAF (1–16 mg/mL) for 72 hours. The cell
proliferation was then determined by means of BrdU assay, and the
results demonstrated that IPAF stimulated CD19
+ B lymphocytes in
cell proliferation directly and dose-dependently (Fig. 3B). Neverthe-
less, this effect was absent in IPAF treated T lymphocytes, suggesting
Figure 1. Purification and biochemical characteristics of IPAF. (A) Crude protein extracts were fractionated by a DEAE-52 cellulose column
eluted with linear gradient of 0.0–1.0 M NaCl. The elution profile was generated based on protein concentration determined by BCA analysis. (B) The
active fractions were further purified using FPLC system equipped with a HiTrapQ anion exchange column eluted with lineargradient of 0.0–1.0 M NaCl.
The elution profile was generated by measuring the absorbance at 280 nm. (C) Purified IPAF was identified by SDS-PAGE with Coomassie brilliant blue
(lane2)andperiodicacid-Schiffstaining(lane3). PurifiedIPAF was transferredtoPVDF membraneandidentified viawestern blot usinga self-made mAb
against IPAF (lane 4). The molecular weight of IPAF was determined by comparing with pre-stained protein markers (lane 1). (D) Gel-filtration capillary
electrophoresisSDS-MW analysisofIPAFpreparedunder reducingornon-reducingcondition. TheMWwasderivedbynormalizingthemigration timeof
the samples with the 10 kDa internal standard, and calibrated with the standard curve constructed with the protein size standard.
doi:10.1371/journal.pone.0021004.g001
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PLoS ONE | www.plosone.org 3 June 2011 | Volume 6 | Issue 6 | e21004Figure 2. Molecular cloning of IPAF. (A) Complete nucleotide sequence of IPAF cDNA was derived by RACE PCR using specific primers of IPAF. The ORF
of IPAF cDNA ispresented in capital letters, the termination codon is marked with anasterisk, and the 39-UTR is displayed in lower case letters. In the amino acid
sequence, the putative signal peptide cleavage site between Ala25 and Ala26, as predicted by SignalP, is showed with a vertical arrow,a n dt h eN - t e r m i nal
amino acid sequence is indicated with a grey background. (B) Genomic structure of IPAF gene. The numbers represent base pair positions in the genomic
sequence. The putative signal peptide, IPAF gene, and 39-UTR are presented with white, grey, and dark-grey background, respectively. The vertical arrow
indicates the corresponding cleavage site of the signal peptide. (C) Multiple alignment of IPAF amino acid sequence with sequences of lectins from
Orchidaceae plants was performed by ClustalW2 program on the website of EMBL-EBI. The identical and the similar residues are marked with asterisks and
dots, respectively.
doi:10.1371/journal.pone.0021004.g002
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IPAF (Fig. 3B). In accordance with this observation, the result of
FACS assay demonstrated that IPAF exhibited minor stimulating
effect on T lymphocyte proliferation (Fig. 3C). The cell proliferation
level of IPAF-induced B lymphocytes, however, markedly increased
by 2.61-fold as compared with control (Fig. 3D). Taken together,
these data suggested that B lymphocytes could be the main targets to
be activated by IPAF.
IPAF stimulated activation and maturation of B lymphocytes
Based on the findings that B lymphocytes were the main cells
stimulated and proliferated by IPAF, whether IPAF caused the cell
activation and development of mouse splenic B lymphocytes or not
was evaluated using the FACS approach. The lymphocyte
activation marker CD69 expression by MACS purified IPAF-
induced B lymphocytes was examined, and an 8.46-fold elevation
in CD69 expression was attained (Fig. 4A). In addition, B
lymphocytes are antigen presenting cells that bridged the innate
and adaptive immunity, therefore, antigen presenting ability of
IPAF-treated B lymphocytes was investigated. The MHC class II
expression was 1.44-fold higher in IPAF-induced B lymphocytes
than in untreated cells (Fig. 4B). These data indicated that IPAF
was capable of activating the development and maturation of
mouse splenic B lymphocytes and strengthen their antigen
presenting ability by elevating MHC class II expression.
IPAF enhanced IgM but not IgG production in B
lymphocytes
The sole weapon of B lymphocytes against microorganism
pathogens is the secretion of neutralizing antibodies. The capability
of IPAF alone in modulating antibody production in mouse splenic
B lymphocytes was determined by ELISA quantification methods.
MACS purified IPAF-treated B lymphocytes exhibited consistent
and time-dependent enhancement in IgM production (Fig. 5A). As
fully activated B lymphocytes would undergo Igs isotype switch and
shift from IgM secreting plasma cells to IgG secreting plasma cells,
the levels of IgG in the cell culture supernatant were measured. It
was observed that IgG production was not affected by IPAF within
72 hours of induction (Fig. 5B). We then investigated the dose effect
of IPAF on the antibody production by the B lymphocytes and
revealed that IgM production by IPAF-treated B lymphocytes
increased dose-dependently, while IgG production was unaffected
(Fig. 5C). These data confirmed that IPAF was capable to enhance
IgM production by B lymphocytes in time- and dose-dependent
manners.
IPAF-induced B lymphocyte activation was TLR2/TLR4
independent
Several studies have described the possible involvements of
TLRs in the activation of B lymphocytes [20–22]. In preliminary
studies, we have discovered that IPAF stimulated mouse primary
peritoneal macrophages mainly through TLR4 (Supporting
information S8). To investigate the involvement of TLR2/TLR4
in IPAF-induced B lymphocyte activation, we purified splenic B
lymphocytes from C57BL/10ScN (TLR4
2/2) and B6.129-
TLR2tmlkir/J (TLR2
2/2), and evaluated their responses to
IPAF. As shown in Fig. 6A, the stimulating effect of IPAF on
cell proliferation was significant both in C57BL/10ScN and
B6.129-TLR2tmlkir/J B lymphocytes. We further examined the
elevating effect of IPAF on CD69 and MHC class II expressions
by C57BL/10ScN and B6.129-TLR2tmlkir/J B lymphocytes and
found that the expression levels of CD69 and MHC class II were
significantly upregulated despite the lack of TLR4 and TLR2
receptors (Supporting Information S9, S10, S11, S12). After the
analysis of the IgM and IgG production level of IPAF treated
C57BL/10ScN and B6.129-TLR2tmlkir/J B lymphocytes, similar
results where IgM production was significantly increased in a time
dependent manner was observed (Fig. 6B), and IgG production
was unaffected (Fig. 6C). Based on these findings, we suggested
that neither TLR4 nor TLR2 were the major receptor of IPAF to
exert the stimulating effects in mouse splenic B lymphocytes.
Discussion
In this study, IPAF which possessed significant stimulating effect
toward mouse splenic B lymphocyte was purified and cloned. To
our knowledge, it is the first report to characterize an
immunomodulatory protein of the Orchidaceae plant A. formosa-
nus. The MW of IPAF determined by SDS-PAGE (,14 kDa) and
gel-filtration capillary electrophoresis (14.3 kDa) agreed well with
the MW deduced from the amino acid sequence (14.4 kDa). The
discovery of non-reduced and reduced IPAF possessing nearly
identical MW also confirmed that IPAF was a monomeric protein.
IPAF was a non-glycosylated protein and the translated IPAF
contained putative signal peptide of 25 residues, which might be
cleaved in post-translational modification or secretion. The mature
IPAF encoded 133 amino acids with a MW of 14 kDa, which was
similar to those of lectins (,13 kDa) isolated from L. Ovata, E.
helleborine and Cymbidium hybrid [23]. The MW of the IPAF
putative signal peptide was 2.45 kDa based on its amino acid
sequence. Notably, the cDNA sequences of lectins of L. Ovata, E.
helleborine and Cymbidium hybrid all contained a 2.5 kDa signal
peptide [24]. Protein BLAST comparison and multiple alignment
of the amino acid sequence of IPAF within NCBI database
revealed its high similarity to the lectins from Orchidaceae plants,
including E. helleborine lectin (AAA19577.1), gastrodianin-4B of G.
elata (AAX10109.1), and lectin of L. ovata (AAA20899.1). Although
the physiological functions of E. helleborine and L. ovata lectins were
not well understood, Gastrodianin-4B which abundantly expressed
in the above-ground organs of G. elata was considered as an
important defensive protein against fungus Armillaria. Its elevated
Table 1. Amino acid sequence comparison of IPAF with lectins from Orchidaceae plants.
Species Name Access No. Length Identity(%) Similarity(%) Gap(%)
A. formosanus IPAF ADK74829.1 158 - - -
E. helleborine lectin AAA19577.1 172 57 68 2
G. elata gastrodianin-4B AAX10109.1 171 51 66 1
L. ovata lectin AAA20899.1 175 51 65 3
a) The identity values were calculated as (numbers of amino acid residues identical to IPAF/numbers of IPAF amino acid residues).
b) The similarity values were calculated as (numbers of amino acid residues similar to IPAF/numbers of IPAF amino acid residues).
c) The gap values were calculated as (numbers of gaps/numbers of IPAF amino acid residues).
doi:10.1371/journal.pone.0021004.t001
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responsible for the defenses against other plant pathogens [25].
Based on the high sequence similarity between IPAF and
gastrodianin-4B, and the fact that the above-ground organs of A.
formosanus contributed more than 80% of the processed plant
weight, the physiological function of IPAF in A. formosanus was
assumed to resemble gastrodianin-4B, as a defensive molecule
against phytopathogens. Our hemagglutination assay showed that
IPAF possessed no agglutinating activity toward human and
mouse erythrocytes. Interestingly, Van Damme et al. [19] also
discovered a group of lectins from E. helleborine and L. ovata which
were unable to agglutinate erythrocytes. In that study, it was
suggested that the monomeric nature of those lectins might be the
reason of their inability to agglutinate erythrocyte. This again was
Figure 3. IPAF stimulated the cell proliferation of mouse splenic B lymphocytes. (A) Splenocytes harvested from BALB/c (5610
5 cells per
well) were treated with IPAF of indicated concentrations for 72 hours, cell proliferation was determined by BrdU assay. (B) MACS purified splenic T
(CD90
+) cells and B (CD19
+) cells from BALB/c were treated with IPAF of indicated concentrations for 72 hours, cell proliferation was determined by
BrdU assay. (C) Splenocytes harvested from BALB/c were treated with medium (left), 8 mg/mL IPAF (middle), 5 mg/mL conA (right) for 72 hours. Cells
were harvested and stained with PE-labeled anti-mouse CD3 and PI for flow cytometry analysis. T cells were gated based on CD3 fluorescence, and
proliferating cells were determined based on PI fluorescence intensity. Data are presented as percentage of proliferating cells in total cells. (D)
Splenocytes harvested from BALB/c were treated with medium (left), 8 mg/ml IPAF (middle) and 5 mg/mL LPS (right) for 72 hours. Cells were
harvested and stained with FITC-labeled anti-mouse CD45R/B220 and PI for flow cytometry analysis. B cells were gated based on CD45R/B220
fluorescence, and proliferating cells were determined based on PI fluorescence intensity. Data are presented as percentage of proliferating cells in
total cells.
doi:10.1371/journal.pone.0021004.g003
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PLoS ONE | www.plosone.org 6 June 2011 | Volume 6 | Issue 6 | e21004Figure 4. IPAF stimulated the expression markers in mouse splenic B lymphocytes. (A) Splenic B lymphocytes of BALB/c were stimulated
with 30 mg/mL IPAF (middle), 10 mg/mL LPS (right), or medium alone (left) for 24 hours. Cells were stained with PE-labeled anti-mouse CD69 for flow
cytometry analysis. Data are presented as percentage of CD69 positive cells in total cells. (B) Splenic B lymphocytes of BALB/c were stimulated with
30 mg/mL IPAF (middle), 10 mg/mL LPS (right), or medium alone (left) for 24 hours. Cells were stained with FITC-labeled anti-mouse MHC class II for
flow cytometry analysis. Data are presented as percentage of MHC class II positive cells in total cells.
doi:10.1371/journal.pone.0021004.g004
Figure 5. IPAF enhanced IgM production in purified mouse B lymphocytes. (A) IgM production and (B) IgG production by MACS-purified
CD19
+ B lymphocytes of BALB/c were treated with 30 mg/mL of IPAF (N), medium (#), or 10 mg/ml LPS (m) for 0, 24, 48 and 72 hours. The Igs
production was determined by ELISA. Results are shown as mean 6 SD in triplicate (n=3). (C) B lymphocytes of BALB/c were treated with IPAF of
indicated concentrations for 48 hours. IgM (N) and IgG (#) production were determined by ELISA. Results are shown as mean 6 SD in triplicate (n=3).
doi:10.1371/journal.pone.0021004.g005
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PLoS ONE | www.plosone.org 7 June 2011 | Volume 6 | Issue 6 | e21004Figure 6. TLR2 and TLR4 were not involved in the IPAF-induced activation of mouse splenic B lymphocytes. (A–B) B lymphocytes of
C57BL/10ScN (TLR4
2/2) and B6.129-TLR2tmlkir/J (TLR2
2/2) were treated with 30 mg/mL of IPAF (N), medium (#), or 10 mg/mL LPS (m) for 0, 24, 48 and
72 hours, the IgM (A) and IgG (B) production were determined by ELISA. (C) B lymphocytes of C57BL/10ScN and B6.129-TLR2tmlkir/J were treated
with or without 30 mg/ml IPAF for 48 hours, and the cell proliferation was analyzed by Brd-U assay. Results are shown as mean 6 SD in triplicate
(n=3). *P,0.05 versus control.
doi:10.1371/journal.pone.0021004.g006
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agglutinated neither human nor mouse erythrocytes. According to
the study of Van Damme et al., lectins are ubiquitous in different
tribes of the family of Orchidaceae [23]. Based on our discoveries,
we believed that IPAF was a new lectin or a lectin-like protein of
the Orchidaceae lectin family.
Lectins are ubiquitous in nature, and in the higher plant, myriad
of them are known to possess immunostimulating activity. For
examples, lectins from mistletoe (Viscum album) were reported to be
capable of elevating the population and activity of murine natural
killer cell both in vitro and in vivo [24]; lectins from garlic (Allium
sativum) were reported to proliferate murine thymocytes and
splenocytes [26]; banana lectin from Musa pradisiac exhibited
proliferation potential in CD3
+, CD4
+, and CD8
+ cell populations
of human PBMCs [27]; lectin from Narcissus tazetta displayed
capability of activating murine macrophage and splenocytes [28];
lectin from the seeds of Momordica charantia activated murine B
lymphocytes and induced their polyclonal IgM secretion in a T
cell independent manner [29]. Since there hasn’t been any report
of Orchidaceae lectin regarding the immunomodulatory efficacy,
this is the first article to elucidate the immunological function of an
Orchidaceae lectin-like protein, IPAF, as an activator of murine B
lymphocyte.
We discovered that B lymphocyte was the major target cell
responsible to IPAF induced cell proliferation. IPAF could directly
stimulate the purified B (CD19
+) cells in the absence of T cells.
Moreover, IPAF was capable of activating the development and
maturation of purified B lymphocytes in view of the increased
expression of CD69 and MHC class II, and the significant
enhancement of IgM production. This characteristic selective
activation of B lymphocytes by IPAF resembled that of the lectin
isolated from Momordica charantia, which also specifically activated
murine B lymphocytes, possibly through selective binding of cell
specific carbohydrate [29]. Another similar mitogenic substance,
which primarily activated B cells, inducing the cell proliferation and
IgMsecretion wasfound in the seedsofUlexeuropeus[30]. Still another
pure B cell activator was Staphylococcus aureus Cowan I (SAC), which
acted on B cells by cross-linking the Igs receptors on the B cell surface
and triggered the cell proliferation [31]. It was exhibited that IPAF
followed an analogous activation pattern of Momordica charantia lectin,
Ulex mitogen, or SAC, in which B lymphocytes were immediately
stimulated without the aid from T lymphocytes or any other
accessory cells. Furthermore, it was believed that typical TI-2
antigens acted by cross-linking BCRs and co-receptors through their
highly repetitive epitopes such as cell-wall polysaccharides of
pneumococcus (Streptococcus pneumoniae). Considering the fact that
IPAF was a purified soluble protein possessing none of the
characteristics of any typical TI-2 antigens, we assumed that IPAF
might be a TI-1 antigen, which triggered B cell differentiation to
IgM-secreting plasma cells through BCR ligation along with
additional stimulations provided by other signaling molecules [32].
Additional researches are required to clarify the above assumption.
On the other hand, the cytokines and molecular signals provided by
the effector T helper cells were required for the isotype switching of
antibodies secreted by B lymphocyte [32]. It was reasonable to
discover that the IgG production of purified B cells was scarcely
affected by IPAF induction.
Preliminary experiments indicated that TLR4 could be the
dominating receptor of IPAF on murine peritoneal macrophages
(Supporting Information S8). TLRs are pattern recognition receptors
in sensing molecules and could deliver stimulating signals toward B
lymphocytes [20–22]. Therefore, TLRs (especially TLR4 and TLR2
recognizing the peptidoglycan and protein ligands, respectively) were
possible responding molecules for IPAF in murine B lymphocytes.
However, the significant stimulative effect of IPAF on the cell
proliferation and IgM production still persisted in the B cells of both
TLR4
2/2 (C57BL/10ScN) and TLR2
2/2 (B6.129-TLR2tmlkir/J)
mice. Based on these results, it was inferred that neither TLR4 nor
TLR2 were the major receptor of IPAF, notwithstanding, further
investigation was required to elucidate the receptor and the signaling
network of B cell activation induced by IPAF.
In conclusion,this studyisthefirst topurifyandclone animmune
regulator protein from A. formosanus. IPAF was capable of activating
the cell proliferation, maturation, and IgM production by mouse
splenic B lymphocytes in a T cell independent manner through a
TLR2/4 independent mechanism. Our observations provided new
insight to discover functional protein from Orchidaceae plant
regarding the immunomodulating ability toward mammalian cells.
Materials and Methods
Purification of IPAF
Tissue cultured Anoectochilus formosanus plant was purchased from
Yo-Rong farm (Puli, Taiwan). The whole plants were cleaned,
minced, weighed and then immersed in equal weight of extraction
buffer containing 5% (v/v) acetic acid, 0.1% (v/v) 2-mercapto-
ethanol, and 0.308 M sodium chloride. The samples were then
homogenized using a Waring Laboratory blender (Waring
Laboratory, Torrington, WY) and subjected to sonication by
Sonicator XL2015 (MISONIX, Farmingdale, NY) to yield plant
extracts. The extracts were subsequently sieved with a screen mesh
and centrifuged at 10,000 rpm at 4uC for 1 hour to remove plant
residuals and debris. Supernatant containing crude protein was
treated with 30% saturation of ammonium sulfate and left
standing for 24 hours for protein precipitation. After precipitation
by ammonium sulfate, crude protein solution was centrifuged at
10,000 rpm at 4uC for 1 hour, and the precipitates were collected,
suspended and dialyzed in 0.01 M Tris-HCl buffer (pH 8.2) for
72 hours with at least six changes of dialysis solution. The dialysate
was then loaded on a DEAE 52 cellulose (Whatman, Maidstone,
UK) column (2.5620 cm) pre-equilibrated with 0.01 M Tris-HCl
buffer (pH 8.2) for fractionation. The column was eluted with
linear gradient of 0.0–1.0 M NaCl. The main active fractions
(Fig. 1A) were pooled and further purified by FPLC system with a
HitrapQ anion exchange column (GE Healthcare, Buckingham-
shire, UK) eluted with a linear gradient of 0.0–1.0 M NaCl. The
resulting fractions containing IPAF (Fig. 1B) were then dialyzed in
PBS and concentrated to appropriate conditions.
Electrophoresis analysis and western blotting
Purified IPAF was analyzed by SDS-PAGE with a Bio-Rad mini
protein III gel apparatus (Bio-Rad, Hercules, CA). Molecular
weight of IPAF was determined on the basis of the migration on gel
relatively to pre-stained protein marker (GE Healthcare). The gels
were stained with Coomassie brilliant blue R250 (CBR) to visualize
protein or with periodic acid-Schiff (PAS) reagent to determine
carbohydrate contents. Purified IPAF was separated by SDS-PAGE
and transferred onto polyvinylidene difluoride (PVDF) Immobilon
P (Millipore,Billerica,MA)membrane using Trans-Blot Cell system
(Bio-Rad) in transfer buffer. The PVDF membrane was blocked
withPBScontaining5%BSA(Sigma-AldrichSt.Louis,MO)at4uC
overnight. The PVDF membrane was then subjected to western
blotting with anti-IPAF monoclonal antibody produced in our
laboratory.
Gel – filtration capillary electrophoresis analysis
Two sets of IPAF samples, reduced and non-reduced, were
prepared for gel-filtration capillary electrophoresis (GFCE)
analysis using the SDS-MW Analysis Kit (Beckman Coulter,
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adjusted to 0.5 mg/mL with sample buffer, 2 mL of internal
standard (synthetic peptide with MW of 10 kDa) and 5 mgo f2 -
mercaptoethanol was added to 95 mL of protein sample. The
sample was then heated in water bath at 100uC for 3 min. The
non-reduced IPAF was prepared by adjusting protein concentra-
tion to 0.5 mg/mL with sample buffer, and adding 2 mLo f
internal standard to 95 mL of protein sample. The sample was
subsequently heated in water bath at 65uC for 3 min. The protein
size standard (synthetic peptides with MW of 10, 20, 35, 50,
100 kDa) was prepared following manufacturer’s instructions. The
size standard and samples were then loaded onto PA 800 plus
Pharmaceutical Analysis System (Beckman Coulter, Brea, CA) for
GFCE analysis. The results were analyzed with 32 Karat
TM
Version 9.0 and PA 800 plus Software. The MW was derived by
normalizing the migration time of the samples with the 10 kDa
internal standard, and calibrated with the standard curve
constructed with the protein size standard.
N-terminal amino acid sequence analysis
Purified IPAF was separated by SDS-PAGE and transferred
onto PVDF membrane using Trans-Blot Cell system (Bio-Rad) in
transfer buffer. The protein band corresponding to IPAF was cut
from CBR stained membrane and subjected to Edman degrada-
tion. Automated Edman degradation and sequence analysis were
carried out on an Applied Biosystems Procise Sequencer (Mission
Biotech, Taipei, Taiwan).
Molecular cloning of IPAF gene
To clone the cDNA of IPAF, total RNA of A. formosanus was
extracted and RACE was carried out as described thoroughly in
our previous report [33]. In brief, total RNA was extracted from A.
formosanus using Qiagen RNeasy Plant Mini Kit (Qiagen, German-
town, MD) according to the manufacturer’s instruction and then
utilized to synthesize the template cDNA by employing the
Thermoscript RT-PCR system (Invitrogen, Carlsbad, CA). 39
RACE-PCRs were conducted using 39-SMART RACE cDNA
Amplification Kit (Clontech, Mountain View, CA) and a gene-
specific primer a36 (59-GCCAGTAGTTTAGGNACTGG- 39)
degenerated from the IPAF N-terminal amino acid sequence. A
700 bp PCR product (PRa36 fragment) was then cloned into
pGEM-T Easy vector (Promega, Madison, WI) which was
subsequently transformed into E. coli DH5R, and the colonies
were selected for plasmid DNA extraction and sequencing. The 59
end of IPAF was acquired by utilizing the 59-SMART RACE
cDNA Amplification Kit (Clontech) with a b18 primer (59-
GACGTTCTGTGGCTTATAAAT – 39), designed based on the
sequence of PRa36 fragment. A 600 bp PCR product (PRb18
fragment) was cloned and sequenced via the same method. After
aligning PRa36 and PRb18 fragments, the complete sequence of
IPAF cDNA was attained. This sequence was amplified and
validated by independent PCR cloning using IPAF-specific primer
located amid 59- and 39-UTR) of IPAF cDNA, and compared for
homologous gene using the BLAST program purveyed by NCBI
(http://www.ncbi.nlm.nih.gov/BLAST). Multiple alignment of
IPAF amino acid sequence with other sequences was conducted
by the ClustalW2 [34] program on the website of EMBL-EBI
(http://www.ebi.ac.uk/Tools/clustalw2).
Mice and cell culture
BALB/c mice between 6 to 8 weeks of age were purchased from
the National Laboratory Animal Center, Taipei, Taiwan. TLR4
deficient C57BL/10ScN and TLR2deficient B6.129-TLR2tmlkir/J
were purchased from The Jackson Laboratory. The mice were
maintained in our animal facility under pathogen-free condition. All
animal studies were permitted by the Institutional Animal Care and
UseCommitteeofNationalTaiwanUniversity(ApprovalID:NTU-
IACUC-98-112), and performed according to the regulations of the
NTU-IACUC. Mice were splenectomized after euthanasia for
splenocytes acquisition, cells were suspended in DMEM medium
(Hyclone, Logan, Utah) containing 10% heat inactivated fetal
bovine serum (FBS) (GIBCO-BRL Life Technologies, New York,
NY) and cultured in 96-well microplate (Corning, Lowell, MA) at
cell density of 5610
5 per well in Hera Cell (Heraeus group, Hanau,
Germany) at 37uCw i t h5 %C O 2 humidified air. T and B
lymphocytes were positively selected from total splenocytes by
MACS separation system (Miltenyi Biotec, Bergisch Gladbach,
Germany) using anti-mouse CD90 and anti-mouse CD19 microbe-
ads, respectively. The purities of T lymphocytes and B lymphocytes
were above 95% as analyzed by flow cytometry.
Fluorescence-activated cell sorting (FACS)
For cell surface markers and MHC class II detection, cells
were suspended in FACS buffer containing 0.2% (v/v) FBS
and 0.01% (w/w) sodium azide and stained with FITC-labeled
anti-mouse CD45R/B220, PE-labeled anti-mouse CD3, PE-
labeled anti-mouse CD69, or FITC-labeled anti-mouse MHC
class II antibodies (eBioscience, San Diego, CA) at 4uCf o r
30 minutes in dark. For DNA detection, cells were washed
twice and suspended with FACS buffer (150 mL/10
6 cells)
before fixed by 100% ethanol (350 mL/10
6 cells) at 220uCf o r
30 minutes and then stained with PI/RNase staining buffer
(BD Biosciences, San Jose, CA). Cells were then analyzed with
FACScan and these data were acquired by CellQuest software
(BD Biosciences). The results were expressed as percentage of
positive fluorescent cells.
Measurement of cell proliferation
The cell proliferation was determined based on the measure-
ment of BrdU uptake by the cells using Cell proliferation ELISA
Brd-U kit (Roche, Basel, Switzerland) following manufacturer’s
instructions. The results were acquired by microplate reader 3550-
UV (Bio-Rad).
Measurement of immunoglobulin production
The levels of mouse IgM and IgG production in cell culture
supernatant were analyzed using Mouse IgM and Mouse IgG
ELISA quantification kits (Bethyl Laboratories, Inc, Montgomery,
TX.), respectively, according to manufacturer’s instructions. The
concentrations of IgM and IgG were calculated by comparing with
recombinant mouse IgM and IgG as standards. The results were
acquired by microplate reader 3550-UV (Bio-Rad).
Production of anti-IPAF monoclonal antibody
BALB/c mice were immunized by monthly intraperitoneal
injections of 50 mg purified IPAF, which was mixed with an
appropriate volume of aluminum potassium sulfate (10% w/v).
Splenocytes from immunized mice were fused 3 days after an
intraperitoneal injection of immunogen with mouse X63Ag8.653
myeloma cells from the American Type Culture Collection
(ATCC; Manassas, VA) using 50% polyethylene glycol 1500
(Roche). Hybridoma was selected in a hypoxanthine-aminopterin-
thymidine medium (Gibco/BRL Life Technologies, Eggenstein,
Germany) and the supernatants were screened by conventional
immunoenzymatic assays using purified IPAF as a tracer. The cells
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method. Monoclonal antibodies were purified from the superna-
tant of hybridoma culture by protein A/G affinity chromatogra-
phy (GE Healthcare).
Data analysis
All experimental results are presented as mean 6 SD of three
independent experiments performed in triplicates (n=3). Statisti-
cal comparisons were performed by one way ANOVA using PC-
SAS (Statistical Analysis System, SAS Institute., USA) and
differences between experimental data were determined to be
significant at P value,0.05.
Supporting Information
Supporting Information S1 Induction of TNF-a production in
RAW 264.7 macrophages by active protein fraction eluted with
DEAE-52 column. RAW 264.7 macrophages were cultured in 96-
well plate and stimulated with 0, 10, 20, 30, and 40 mg/ml active
protein fraction eluted with DEAE-52 column for 24 hours. TNF-
a concentration in the culture supernatant was determined by
ELISA using mouse recombinant TNF-a as standard.
(TIF)
Supporting Information S2 SDS-PAGE analysis of the active
protein fractions eluted with DEAE-52 column. The active protein
fractions eluted with DEAE-52 column were analyzed by SDS-
PAGE 20 ml of fraction 8, 10, 12, 14, 16, 18, 20, 22, and 24 were
loaded in lane 2, 3, 4, 5, 6, 7, 8, 9, and 10 respectively, and
molecular weight of protein was determined by comparison
between prestained protein marker.
(TIF)
Supporting Information S3 IPAF stimulated TNF-a secretion
in RAW264.7 macrophages. RAW 264.7 cells were cultured in 96-
well plate (5610
5 cells/well) and treated with indicated concentra-
tions of IPAF for 24 hours. TNF-a concentration in the culture
supernatant was determined by ELISA using mouse recombinant
TNF-a as standard.
(TIF)
Supporting Information S4 IPAF Stimulated IFN-c secretion
in mouse splenocytes. Splenocytes harvested from BALB/c were
treated with or without 8 mg/ml IPAF for 72 hours. IFN-c
concentration in the culture supernatant was determined by ELISA
using mouse recombinant IFN-c as standard.
(TIF)
Supporting Information S5 Alignment of the 39-RACE and
59-RACE products and the deduced amino acid sequences. 39-
RACE PCR was performed using a gene specific primer a36 (red
arrow), which was degenerated from the N-terminal amino acid
sequence (green). By taking advantage of the PRa36 sequence,
primer b18 (blue arrow) was designed and by which the 59-RACE
PCR was conducted. The complete nucleotide sequence of IPAF
cDNA was obtained through merging the corresponding sequenc-
es of PRa36 and PRb18.
(TIF)
Supporting Information S6 Signal peptide prediction of IPAF.
Putative signal peptide was predicted by SignalP prediction
program Using neural networks (NN) and hidden Markov models
(HMM) trained on eukaryotes.
(TIF)
Supporting Information S7 Hemagglutination assay of IPAF on
humanandmouseerythrocyte.IPAFandfungalimmunomodulatory
protein (FIP)-fve were adjusted to 1 mg/mL with PBS, and two-fold
serial dilution was performed. 100 mL/well of protein sample was
placed in U bottom 96-well plate, and 50 mL of 3% erythrocyte
solution was added to each well. The plate was incubated at room
temperature for 1 hour and the result was recorded with a digital
camera. FIP-fve served as positive control where the positive wells
were clouded due to hemagglutination. The erythrocyte in the IPAF
solution all precipitated within an hour, leaving a clear zone around
the erythrocyte pellet.
(TIF)
Supporting Information S8 The involvement of TLR4 in the
IPAF-induced activation of murine peritoneal macrophages.
Peritoneal macrophages isolated from C57BL/6 and C57BL/
10ScN (TLR4
2/2) mice were treated with 8 mg/ml IPAF for the
indicated period, and TNF-a concentrations were determined by
ELISA using recombinant mouse TNF-a as standard.
(JPG)
Supporting Information S9 IPAF enhanced CD69 expression
in splenic B lymphocytes of C57BL/10ScN. B lymphocytes
purified from C57BL/10ScN, incubated in 96-well plate (3610
5
cells per well), and stimulated with 30 mg/ml IPAF, 10 mg/ml LPS
or medium alone for 24 hours. Cells were then stained with PE-
labeled anti-mouse CD69 for flow cytometry analysis. Data are
presented as percentage of CD69
+ cells in total cells.
(TIF)
Supporting Information S10 IPAF enhanced MHC class II
expression in splenic B lymphocytes of C57BL/10ScN. B
lymphocytes purified from C57BL/10ScN, incubated in 96-well
plate (3610
5 cells per well), and stimulated with 30 mg/ml IPAF,
10 mg/ml LPS or 200 ng/ml IFN-c or medium alone for
24 hours. Cells were then stained with FITC-labeled anti-mouse
MHC class II for flow cytometry analysis. Data are presented as
percentage of MHC II
+ cells in total cells.
(TIF)
Supporting Information S11 IPAF enhanced CD69 expres-
sion in splenic B lymphocytes of B6.129-TLR2tmlkir/J. B
lymphocytes purified from B6.129-TLR2tmlkir/J, incubated in
96-well plate (3610
5 cells per well), and stimulated with 30 mg/ml
IPAF, 10 mg/ml LPS or 200 ng/ml IFN-c or medium alone for
24 hours. Cells were then stained with PE-labeled anti-mouse
CD69 for flow cytometry analysis. Data are presented as
percentage of CD69
+ cells in total cells.
(TIF)
Supporting Information S12 IPAF enhanced MHC class II
expression in splenic B lymphocytes of B6.129-TLR2tmlkir/J. B
lymphocytes purified from B6.129-TLR2tmlkir/J, incubated in
96-well plate (3610
5 cells per well), and stimulated with 30 mg/ml
IPAF, 10 mg/ml LPS or 200 ng/ml IFN-c or medium alone for
24 hours. Cells were then stained with FITC-labeled anti-mouse
MHC class II for flow cytometry analysis. Data are presented as
percentage of MHC II
+ cells in total cells.
(TIF)
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